These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9164927)

  • 1. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo.
    Koo GC; Blake JT; Talento A; Nguyen M; Lin S; Sirotina A; Shah K; Mulvany K; Hora D; Cunningham P; Wunderler DL; McManus OB; Slaughter R; Bugianesi R; Felix J; Garcia M; Williamson J; Kaczorowski G; Sigal NH; Springer MS; Feeney W
    J Immunol; 1997 Jun; 158(11):5120-8. PubMed ID: 9164927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
    Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
    Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels.
    Koo GC; Blake JT; Shah K; Staruch MJ; Dumont F; Wunderler D; Sanchez M; McManus OB; Sirotina-Meisher A; Fischer P; Boltz RC; Goetz MA; Baker R; Bao J; Kayser F; Rupprecht KM; Parsons WH; Tong XC; Ita IE; Pivnichny J; Vincent S; Cunningham P; Hora D; Feeney W; Kaczorowski G
    Cell Immunol; 1999 Nov; 197(2):99-107. PubMed ID: 10607427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion channels and lymphocyte activation.
    Panyi G; Varga Z; Gáspár R
    Immunol Lett; 2004 Mar; 92(1-2):55-66. PubMed ID: 15081528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
    Beeton C; Barbaria J; Giraud P; Devaux J; Benoliel AM; Gola M; Sabatier JM; Bernard D; Crest M; Béraud E
    J Immunol; 2001 Jan; 166(2):936-44. PubMed ID: 11145670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3.
    Rodrigues AR; Arantes EC; Monje F; Stühmer W; Varanda WA
    Br J Pharmacol; 2003 Jul; 139(6):1180-6. PubMed ID: 12871837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of membrane potential in T lymphocytes subpopulations using flow cytometry.
    Mello de Queiroz F; Ponte CG; Bonomo A; Vianna-Jorge R; Suarez-Kurtz G
    BMC Immunol; 2008 Nov; 9():63. PubMed ID: 18980671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kv1.2-containing K+ channels regulate subthreshold excitability of striatal medium spiny neurons.
    Shen W; Hernandez-Lopez S; Tkatch T; Held JE; Surmeier DJ
    J Neurophysiol; 2004 Mar; 91(3):1337-49. PubMed ID: 13679409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases.
    Schmitz A; Sankaranarayanan A; Azam P; Schmidt-Lassen K; Homerick D; Hänsel W; Wulff H
    Mol Pharmacol; 2005 Nov; 68(5):1254-70. PubMed ID: 16099841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive effects of a Kv1.3 inhibitor.
    Shah K; Tom Blake J; Huang C; Fischer P; Koo GC
    Cell Immunol; 2003 Feb; 221(2):100-6. PubMed ID: 12747950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical synthesis and structure-function studies of margatoxin, a potent inhibitor of voltage-dependent potassium channel in human T lymphocytes.
    Bednarek MA; Bugianesi RM; Leonard RJ; Felix JP
    Biochem Biophys Res Commun; 1994 Jan; 198(2):619-25. PubMed ID: 8297371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
    Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
    Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
    Jäger H; Grissmer S
    Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K+ channels and T-cell synapses: the molecular background for efficient immunomodulation is shaping up.
    Matkó J
    Trends Pharmacol Sci; 2003 Aug; 24(8):385-9. PubMed ID: 12915045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidyl inhibitors of shaker-type Kv1 channels elicit twitches in guinea pig ileum by blocking kv1.1 at enteric nervous system and enhancing acetylcholine release.
    Suarez-Kurtz G; Vianna-Jorge R; Pereira BF; Garcia ML; Kaczorowski GJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1517-22. PubMed ID: 10336547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.
    Pucca MB; Bertolini TB; Cerni FA; Bordon KC; Peigneur S; Tytgat J; Bonato VL; Arantes EC
    Immunology; 2016 Feb; 147(2):240-50. PubMed ID: 26595158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ion channels and demyelination: basis of a treatment of experimental autoimmune encephalomyelitis (EAE) by potassium channel blockers].
    Devaux J; Beeton C; Béraud E; Crest M
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S16-27. PubMed ID: 15269656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel alpha-KTx peptides from the venom of the scorpion Centruroides elegans selectively blockade Kv1.3 over IKCa1 K+ channels of T cells.
    Olamendi-Portugal T; Somodi S; Fernández JA; Zamudio FZ; Becerril B; Varga Z; Panyi G; Gáspár R; Possani LD
    Toxicon; 2005 Sep; 46(4):418-29. PubMed ID: 16026809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
    Vennekamp J; Wulff H; Beeton C; Calabresi PA; Grissmer S; Hänsel W; Chandy KG
    Mol Pharmacol; 2004 Jun; 65(6):1364-74. PubMed ID: 15155830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate levels and activity of the T cell voltage-gated potassium Kv1.3 channel in patients with systemic lupus erythematosus.
    Poulopoulou C; Papadopoulou-Daifoti Z; Hatzimanolis A; Fragiadaki K; Polissidis A; Anderzanova E; Davaki P; Katsiari CG; Sfikakis PP
    Arthritis Rheum; 2008 May; 58(5):1445-50. PubMed ID: 18438846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.